Ning S. Wong

London, ENG NW13PG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 23 publications

SCREENing smarter: outperforming IMDC in predicting first-year mortality among patients undergoing cytoreductive nephrectomy.

SCREENing smarter: outperforming IMDC in predicting first-year mortality among patients undergoing cytoreductive nephrectomy.

Journal: World journal of urology

Published: October 04, 2025

Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.

Nivolumab and Ipilimumab for Metastatic Castration-Resistant Prostate Cancer With an Immunogenic Signature: The Multicenter, Two-Cohort, Phase II NEPTUNES Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 28, 2025

Solid tumour cellular therapy - principles of toxicity management.

Solid tumour cellular therapy - principles of toxicity management.

Journal: Immuno-oncology technology

Published: April 16, 2025

The Landscape of Adoptive Cellular Therapies in Ovarian Cancer.

The Landscape of Adoptive Cellular Therapies in Ovarian Cancer.

Journal: Cancers

Published: September 06, 2023

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.

Clonal driver neoantigen loss under EGFR TKI and immune selection pressures.

Journal: Nature

Published: December 16, 2022

Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors.

Systematic Evaluation of the Immune Environment of Small Intestinal Neuroendocrine Tumors.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: November 25, 2021

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital.

Systemic Anti-Cancer Therapy and Metastatic Cancer Are Independent Mortality Risk Factors during Two UK Waves of the COVID-19 Pandemic at University College London Hospital.

Journal: Cancers

Published: October 25, 2021

Frontline Maintenance Treatment for Ovarian Cancer.

Frontline Maintenance Treatment for Ovarian Cancer.

Journal: Current oncology reports

Published: May 03, 2021

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection: the OnCovid Inflammatory Score.

Journal: Journal for immunotherapy of cancer

Published: February 05, 2021

Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective.

Specialist palliative and end-of-life care for patients with cancer and SARS-CoV-2 infection: a European perspective.

Journal: Therapeutic advances in medical oncology

Published: February 03, 2021

The T cell differentiation landscape is shaped by tumour mutations in lung cancer.

The T cell differentiation landscape is shaped by tumour mutations in lung cancer.

Journal: Nature cancer

Published: August 18, 2020

Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience.

Cancer History and Systemic Anti-Cancer Therapy Independently Predict COVID-19 Mortality: A UK Tertiary Hospital Experience.

Journal: Frontiers in oncology

Published: August 17, 2020

Showing 1-12 of 23

Last Updated: 09/26/2026